Published in Anal Biochem on August 01, 1979
A method for difference cloning: gene amplification following subtractive hybridization. Proc Natl Acad Sci U S A (1990) 2.53
Beta-carotene inhibits rat liver chromosomal aberrations and DNA chain break after a single injection of diethylnitrosamine. Br J Cancer (1997) 0.89
Operative treatment of fractures of the tibial plafond. A randomized, prospective study. J Bone Joint Surg Am (1996) 2.34
The malignant potential of enchondromatosis. J Bone Joint Surg Am (1987) 2.15
A prospective, randomized study of the management of severe ankle fractures. J Bone Joint Surg Am (1985) 1.62
Complications encountered in the treatment of pilon fractures. J Orthop Trauma (1992) 1.59
A fluorometric assay for daunomycin and adriamycin in animal tissues. Biochem Med (1973) 1.51
Immunofluorescent detection of adenovirus antigen in epidemic keratoconjunctivitis. Invest Ophthalmol (1976) 1.39
A fluorescence enhancement assay for cellular DNA damage. Mol Pharmacol (1982) 1.10
Publication rates of abstracts presented at the 1993 annual Academy meeting. Clin Orthop Relat Res (1999) 1.09
Hydroxyurea. I. Acute cell death in proliferating tissues in rats. Cancer Res (1967) 1.09
Cytologic diagnosis of adenoviral epidemic keratoconjunctivitis by direct immunofluorescence. Invest Ophthalmol Vis Sci (1977) 1.07
Hydroxyurea: inhibition of deoxyribonucleic acid synthesis in regenerating liver of rats. Cancer Res (1965) 1.01
Acute meprobamate poisoning with gastrotomy and removal of a drug-containing mass. N Engl J Med (1976) 1.01
Marjolin ulcers: secondary carcinomas in chronic wounds. J South Orthop Assoc (1999) 0.98
Cytogenetic, telomere, and telomerase studies in five surgically managed lumbosacral chordomas. Cancer Genet Cytogenet (1995) 0.97
Intramedullary nailing for impending pathological subtrochanteric fractures. J Bone Joint Surg Br (1991) 0.96
Preclinical pharmacology, toxicology and efficacy of sphingomyelin/cholesterol liposomal vincristine for therapeutic treatment of cancer. Cancer Chemother Pharmacol (1998) 0.93
DNA breaks in P288 tumor cells in mice after treatment with daunorubicin and adriamycin. Res Commun Chem Pathol Pharmacol (1975) 0.93
The soft agar clonogenicity and characterization of cells obtained from human solid tumors by mechanical and enzymatic means. Cancer Chemother Pharmacol (1981) 0.92
Heterogeneous survival rates for isolated skeletal metastases from melanoma. Clin Orthop Relat Res (1996) 0.89
Adriamycin and daunorubicin: a comparison of antitumor activities and tissue uptake in mice following immunosuppression. Cancer Res (1973) 0.88
Analysis of variables affecting wound healing after musculoskeletal sarcoma resections. J Surg Oncol (1996) 0.88
Microsatellite instability in sarcomas. Ann Surg Oncol (1998) 0.87
Actinomycin D: drug concentrations and actions in mouse tissues and tumors. Cancer Res (1968) 0.85
Tourniquet infusion versus hyperthermic perfusion. Cancer (1982) 0.85
Comparison of regional versus systemic chemotherapy with adriamycin. Ann Surg (1978) 0.85
Amputation for extremity soft tissue sarcoma does not increase overall survival: a retrospective cohort study. Eur J Surg Oncol (2012) 0.85
Hereditary multiple diaphyseal sclerosis: a tumor simulator. Orthopedics (1990) 0.84
Lumbosacral chordoma resection: image integration and surgical planning. J Surg Oncol (1993) 0.82
Structural allografts for reconstruction of lower extremity open fractures with 10 centimeters or more of acute segmental defects. J Orthop Trauma (1995) 0.82
An analysis of concordance among hospital databases and physician records. Ann Surg Oncol (1998) 0.82
Telomerase activity in skeletal sarcomas. Ann Surg Oncol (1999) 0.82
Degradation of RNA in liver of rats treated with actinomycin D. Mol Pharmacol (1967) 0.81
Microsatellite instability in malignant melanoma. Cancer Genet Cytogenet (1998) 0.81
Geometric properties and the predicted mechanical behavior of adult human clavicles. J Biomech (1993) 0.81
Microsatellite instability in sacral chordoma. J Surg Oncol (2000) 0.80
Tourniquet infusion chemotherapy in extremities with malignant lesions. Surg Gynecol Obstet (1979) 0.79
Methods for the separation and identification of ribonucleotides on DEAE-cellulose. Anal Biochem (1973) 0.79
Initial biotransformations of daunorubicin to aglycones by rat liver microsomes. Cancer Res (1981) 0.79
Actinomycin D effects on nucleic acids during tumor regression. Cancer Res (1968) 0.79
Biotransformations of daunorubicin aglycones by rat liver microsomes. Cancer Res (1984) 0.79
Mechanisms and selectivity of anthracycline aminoglycosides and other intercalating agents. Biomedicine (1976) 0.78
Modes of regional chemotherapy. J Surg Res (1979) 0.78
Membrane actions of daunorubicin in mammalian erythrocytes. Res Commun Chem Pathol Pharmacol (1977) 0.78
Quantitative models for growth inhibition of human leukemia cells by antitumor anthracycline derivatives. Cancer Res (1979) 0.77
Actinomycin D: effects on Ridgway osteogenic sarcoma in mice. Cancer Res (1966) 0.77
Enhanced antitumor activity of adriamycin in combination with allopurinol. Cancer Lett (1983) 0.77
Chromosome telomere integrity of human solid neoplasms. Cancer Genet Cytogenet (1996) 0.77
Growth factor modulation of distraction osteogenesis in a segmental defect model. Clin Orthop Relat Res (2000) 0.77
DNA damage by anthracycline drugs in human leukemia cells. Cancer Lett (1981) 0.76
Adriamycin-induced DNA damage in human leukemia cells. Leuk Res (1979) 0.76
Lack of microsatellite instability in giant cell tumor of bone. Cancer Genet Cytogenet (1996) 0.76
Osteosarcoma oncogene expression detected by in situ hybridization. J Orthop Res (1995) 0.76
Adenovirus types 8 and 19 infection of rabbit corneal organ cultures. Invest Ophthalmol Vis Sci (1979) 0.76
Clear cell sarcoma or malignant melanoma of soft parts: molecular analysis of microsatellite instability with clinical correlation. Cancer Genet Cytogenet (1998) 0.76
TGF-beta and PDGF act synergistically in affecting the growth of human osteoblast-enriched cultures. Connect Tissue Res (1995) 0.76
Identification and analysis of transforming growth factor beta receptors on primary osteoblast-enriched cultures derived from adult human bone. Connect Tissue Res (1992) 0.76
Robertsonian translocations in Paget's disease of bone. J Orthop Res (1997) 0.75
Dental pain and adaptive strain; a place for fatty acid cyclo-oxygenase inhibition. J Oral Med (1981) 0.75
Influence of anesthesia on radiation effect. Experimental cataracts. Radiology (1968) 0.75
Alkali-labile regions and strand breaks in DNA from cells treated with daunorubicin. J Med (1976) 0.75
Dosage and allelic restriction fragment studies and PCR analysis of the H-ras locus in giant cell tumor of bone. Cancer Genet Cytogenet (1994) 0.75
Radiation Therapy Oncology Group. Research Plan 2002-2006. Sarcoma Committee. Int J Radiat Oncol Biol Phys (2001) 0.75
Biochemical parameters of growth inhibition of human leukemia cells by antitumor anthracycline agents. Cancer Treat Rep (1979) 0.75
Competitive binding radioassay for 5-fluorodeoxyuridine 5'-monophosphate in tissues. Cancer Res (1979) 0.75
Primary lymphoma and Paget's disease of the femur. Am J Clin Pathol (1994) 0.75
Chemical interactions of cardiolipin with daunorubicin and other intercalating agents. Eur J Cancer (1979) 0.75
Liposarcoma of the soft tissues. Orthopedics (1987) 0.75
Pathologic acetabular fractures: new concepts in surgical management. Semin Arthroplasty (1994) 0.75
In vitro photodynamic therapy of musculoskeletal neoplasms. J Orthop Res (1993) 0.75
Metabolism of N6-(delta 2-isopentenyl)adenosine in rat liver. Biochem Pharmacol (1974) 0.75
Protein activator of cyclic AMP phosphodiesterase and cyclic nucleotide phosphodiesterase in bovine retina and bovine lens. Activity, subcellular distribution and kinetic parameters. Biochim Biophys Acta (1978) 0.75
An unusual appearance of an aneurysmal bone cyst of the thoracic spine. J Spinal Disord (1991) 0.75
Wood, an organic foreign body of bone. A case report. Clin Orthop Relat Res (1975) 0.75
Functional and chemical markers of PCNU activity. Cancer Drug Deliv (1983) 0.75
Sexual molestation of children. Med Law (1987) 0.75
Bioethical and legal considerations in increasing the supply of transplantable organs: from UAGA to "Baby Fae". Am J Law Med (1985) 0.75
Post-repair DNA damage in X-irradiated cultured human tumour cells. Int J Radiat Biol Relat Stud Phys Chem Med (1980) 0.75
Epithelioid sarcoma. Orthopedics (1987) 0.75
The spinal nail: a new implant for short-segment anterior instrumentation of the thoracolumbar spine. J Spinal Disord (1996) 0.75
Some determinants of the therapeutic efficacy of actinomycin D (NSC-3053), adriamycin (NSC-123127), and daunorubicin (NSC-83142). Cancer Chemother Rep (1974) 0.75
Oral medicine and inhibition of prostaglandin biosynthesis. A preliminary view. J Oral Med (1980) 0.75
Extensive palm thorn hematoma with associated hematuria. Am J Emerg Med (1994) 0.75
Mechanisms of selectivity of intercalating agents. Antibiot Chemother (1971) (1978) 0.75
DNA damage in AML cell exposed to adriamycin; correlations with clinical response to therapy. Leuk Res (1981) 0.75
Hydroxyurea: inhibition of DNA-synthesis and selective susceptibility of S-phase cells in vivo. Acta Genet Med Gemellol (Roma) (1968) 0.75
Organ-specific differences in the metabolism of N6-(delta2-isopentenyl)-adenosine. Biochem Pharmacol (1976) 0.75
Long-term results of pronation-external rotation ankle fracture-dislocations treated with anatomical open reduction, internal fixation. J Orthop Trauma (1990) 0.75
Open biopsy without wound closure for skeletal neoplasms. J Surg Oncol (1991) 0.75
Crossed eyes and halo-pelvic traction. Lancet (1971) 0.75
Molecular analysis of transforming growth factor beta in giant cell tumor of bone. Cancer Genet Cytogenet (1993) 0.75
Hepatic lymphatic mapping: a pilot study for porta hepatis lymph node identification. Cancer Invest (2001) 0.75
Effects of N-trifluoroacetyladriamycin-14-valerate and related agents on DNA strand damage and thymidine incorporation in CCRF-CEM cells. Cancer Res (1979) 0.75
Estimation of the amount of drug absorbed in acetaminophen poisoning: a case report. Vet Hum Toxicol (1981) 0.75